UK consumers decreased their purchases of food and alcohol during the holiday season, with industry experts attributing this trend to the growing popularity of weight loss injections. Grocery sales reached £19.6 billion in the four weeks leading up to December 27, showing a 2.5% increase from the previous year, as reported by market research firm NielsenIQ. However, sales in terms of volume saw a slight decline of 0.2%.
Analysts in the retail sector suggest that the correlation between the drop in food and alcohol sales and the rise in the use of GLP-1 injections, which emulate a hormone that induces feelings of fullness, is evident. The NHS prescribes weight loss injections such as Mounjaro and Wegovy, as well as Ozempic for diabetes, with recent data from University College London estimating that approximately 1.6 million adults in the UK have utilized these injections in the past year.
Experts like Jonathan De Mello, a retail analyst at JDM Retail, noted the impact of these trends, stating that the phenomenon dubbed the “Ozempic effect” is reshaping grocery shopping habits. The preference for lower-calorie options due to the use of GLP-1 injections has influenced sectors like snacks and alcohol, prompting retailers to adjust their product offerings to align with the shift towards more mindful consumption habits.
Retailers have responded to this shift by introducing smaller meal options. For instance, Co-op launched a range of “mini meals” tailored for individuals with smaller appetites, while Marks & Spencer unveiled a new “nutrient-dense” product line, and Iceland expanded its frozen ready meal selection with 38 new offerings.
The impact of weight loss injections on consumer behavior has not gone unnoticed by industry leaders. Greggs’ CEO acknowledged the influence of these medications on the business’s performance, emphasizing the demand for smaller portions and nutritional information in their product range. Tesco’s CEO highlighted the importance of monitoring consumer trends closely in light of the rise in weight loss medication, while Sainsbury’s CEO mentioned their observance of changing shopping behaviors among customers.
As the market continues to adapt to evolving consumer preferences influenced by weight loss treatments, retailers are expected to further innovate and cater to the demand for healthier, portion-controlled options.